Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators
- 19 July 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 8 (9) , 1873-1879
Abstract
The G protein-gated inwardly-rectifying potassium channels (GIRK, Kir3) are a family of inward-rectifying potassium channels, and there is significant evidence supporting the roles of GIRKs in a number of physiological processes and as potential targets for numerous indications. Previously reported urea containing molecules as GIRK1/2 preferring activators have had significant pharmacokinetic (PK) liabilities. Here we report a novel series of 1H-pyrazolo-5-yl-2-phenylacetamides in an effort to improve upon the PK properties. This series of compounds display nanomolar potency as GIRK1/2 activators with improved brain distribution (rodent Kp > 0.6).Keywords
Funding Information
- National Institute of Mental Health (R01MH107399)
This publication has 19 references indexed in Scilit:
- ML297 (VU0456810), the First Potent and Selective Activator of the GIRK Potassium Channel, Displays Antiepileptic Properties in MiceACS Chemical Neuroscience, 2013
- G-protein-gated inwardly rectifying K+ channel 4 (GIRK4) immunoreactivity in chemically defined neurons of the hypothalamic arcuate nucleus that control body weightJournal of Chemical Neuroanatomy, 2012
- Targeting GIRK Channels for the Development of New Therapeutic AgentsFrontiers in Pharmacology, 2011
- Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and diseaseNature Reviews Neuroscience, 2010
- Strategic Use of Plasma and Microsome Binding To Exploit in Vitro Clearance in Early Drug DiscoveryACS Medicinal Chemistry Letters, 2010
- Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological RolesPhysiological Reviews, 2010
- A Novel Assay of Gi/o-Linked G Protein-Coupled Receptor Coupling to Potassium Channels Provides New Insights into the Pharmacology of the Group III Metabotropic Glutamate ReceptorsMolecular Pharmacology, 2008
- The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discoveryMolecular Cancer Therapeutics, 2007
- Recent development of peptide coupling reagents in organic synthesisTetrahedron, 2004
- Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discoveryBiopharmaceutics & Drug Disposition, 2002